✦ LIBER ✦

Enzyme replacement therapy in Fabry disease: Comparison of agalsidase alfa and agalsidase beta

✍ Scribed by Atul Mehta; Michael Beck; Christoph Kampmann; Andrea Frustaci; Dominique P. Germain; Gregory M. Pastores; Gere Sunder-Plassmann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enzyme replacement therapy with agalsida

✍ U Ramaswami; S Wendt; G Pintos-Morell; R Parini; C Whybra; J A Leon Leal; F Sant 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Prospective Results of Switching Enzyme

✍ Michael West; Daniel Bichet; Robin Casey; Joe Clarke; Sandra Sirrs; Gordon Flowe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Enzyme replacement therapy with agalsida

✍ G. Kalkum; D. Macchiella; J. Reinke; H. Kölbl; M. Beck 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Fabry disease: clinical outcomes of agal

✍ C. Wanner 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Hearing loss in Fabry disease: The effec

✍ D. Hajioff; Y. Enever; R. Quiney; J. Zuckerman; K. Mackermot; A. Mehta 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 112 KB

Comparison of the effects of agalsidase

✍ Hitoshi Sakuraba; Mai Murata-Ohsawa; Ikuo Kawashima; Youichi Tajima; Masaharu Ko 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 477 KB